WebMD29d
New Therapy Brings Hope for Dry AMD Vision Loss
7, 2025 – A new light therapy device could be a game-changer for millions at risk of vision loss. The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration ...
These smart glasses help people with macular degeneration by eliminating blind spots
Macular degeneration is one of the leading causes of vision loss, affecting millions worldwide, especially those over 60.
InMed Announces INM-089 Intravitreal Formulation in the Treatment of Dry Age-Related Macular Degeneration
INM-089 IVT formulation selected for continued developmentDemonstrated successful delivery at doses up to 10 times the ...
Hosted on MSN1d
InMed Advances INM-089 for Dry AMD Treatment with New Intravitreal Formulation
InMed Pharmaceuticals ( ($INM) ) has provided an announcement. InMed Pharmaceuticals Inc. announced the selection of an intravitreal formulation ...
Astellas Pharma Submits NDA For Avacincaptad Pegol For Geographic Atrophy In Japan
(RTTNews) - Astellas Pharma Inc. (ALPMY) Wednesday announced the submission of a New Drug Application or NDA in Japan for Conditional Approval of Avacincaptad Pegol intravitreal solution or ACP for ...
Business Wire14h
FDA Approves Genentech’s Susvimo as the First and Only Continuous Delivery Treatment for the Leading Cause of Diabetes-Related Blindness
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...
FiercePharma15h
Roche gains label expansion for eye implant Susvimo to treat diabetic macular edema
Seven months after the FDA signed off on a reintroduction of Roche’s eye implant Susvimo, the U.S. regulator has broadened ...
Macular Degeneration Treatment Market Size is Projected to Reach USD 18.59 Billion by 2033, Growing at a CAGR of 7.06%: Straits Research
The global macular degeneration treatment market size was valued at USD 10.06 billion in 2024 and it is projected to reach ...
ophthalmologytimes17h
FDA approves continuous delivery ranibizumab injection (Susvimo) for the treatment of diabetic macular edema
Susvimo 100 mg/mL for intravitreal use via ocular implant is a refillable implant surgically inserted into the eye during a ...
Macular Degeneration Treatment Market Size, Top Share, Forecast To 2033
Introduction The eye's macula is impacted by macular degeneration, a neurodegenerative condition. Macular degeneration will cause loss of centr ...
InMed Pharmaceuticals: InMed Announces INM-089 Intravitreal Formulation in the Treatment of Dry Age-Related Macular Degeneration
INM-089 IVT formulation selected for continued developmentDemonstrated successful delivery at doses up to 10 times the projected therapeutic level, indicating a favorable pharmacokinetic profile and a ...